港股異動丨中基長壽科學(0767.HK)暴漲逾48% 與深圳市南北醫藥簽署商品採購合同
格隆匯5月31日丨中基長壽科學(0767.HK)高開高走,現漲幅擴大至逾48%,報0.077港元,總市值3億港元。中基長壽科學公吿,於2022年5月27日,公司間接全資附屬公司深圳市中基健康科學有限公司與深圳市南北醫藥有限公司簽署商品採購合同。據此,南北醫藥向中基健康分批採購10萬瓶ZJ1針葉櫻桃複合片,總值人民幣3180萬元。供貨時間根據南北醫藥需要分批次供貨,每次需要以出貨單為準。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.